Investor Information
News
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Summit Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Summit Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference